MORGAN LAMBERT: Open Payments
NPI 1346894938 · ANNISTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 62 payments from 19 companies in 2025. Trend: 2023 $932 · 2024 $1,816 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $194 |
| ABBVIE INC. | 15 | $147 |
| Dexcom, Inc. | 4 | $87 |
| PFIZER INC. | 5 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Exact Sciences Corporation | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Lilly USA, LLC | 3 | $42 |
Products named: Ozempic, Dexcom G6 Transmitter, QULIPTA, Kerendia, Wegovy, Auvelity, XIFAXAN, ELIQUIS.
Industry payments across AL — which companies pay providers there.
